Get Real Time Here
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kintara Therapeutics Stock (NASDAQ:KTRA), Quotes and News Summary
Kintara Therapeutics Stock (NASDAQ: KTRA) stock price, news, charts, stock research, profile.
| Open4.200 | Close4.200 |
| Vol / Avg.5.286K / 158.384K | Mkt Cap7.335M |
| Day Range4.100 - 4.200 | 52 Wk Range2.700 - 15.450 |
Earnings
see more| Q1 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.050 | -1.950 | -0.9000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Maxim Group | Jason McCarthy | Upgrades | HoldBuy | Announces | - | 14.00 |
| 2022-09-29 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
| 2022-05-16 | Dawson James | Jason Kolbert | Downgrades | BuyNeutral | - | - | - |
| 2022-01-20 | HC Wainwright & Co. | Michael King | Maintains | Buy | Lowers | 6.00 | 3.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| KTRA | Kintara Therapeutics | 2.94% | 7.3M |
| MNPR | Monopar Therapeutics | -1.33% | 8.1M |
| ADXN | Addex Therapeutics | -7.51% | 5.5M |
| BRTX | BioRestorative Therapies | -7.64% | 6.8M |
| GRTX | Galera Therapeutics | -2.46% | 7.8M |
How do I buy Kintara Therapeutics (KTRA) stock?
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
Who are Kintara Therapeutics's (KTRA) competitors?
Other companies in Kintara Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), Galera Therapeutics (NASDAQ:GRTX) and Biophytis (NASDAQ:BPTS).
What is the target price for Kintara Therapeutics (KTRA) stock?
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on Friday, July 14, 2023. The analyst firm set a price target for 14.00 expecting KTRA to rise to within 12 months (a possible 233.33% upside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Kintara Therapeutics (KTRA)?
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $4.2 last updated September 27, 2023 at 7:59 PM UTC.
Does Kintara Therapeutics (KTRA) pay a dividend?
There is no dividend information for Kintara Therapeutics.
When is Kintara Therapeutics (NASDAQ:KTRA) reporting earnings?
Kintara Therapeutics’s Q1 earnings are confirmed for Wednesday, November 8, 2023.
Is Kintara Therapeutics (KTRA) going to split?
There is no upcoming split for Kintara Therapeutics.
What sector and industry does Kintara Therapeutics (KTRA) operate in?
Kintara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.